Menstrual cramp patch
Commercial- Indications
- Menstrual cramps
Company intelligence / Profile preview
Remy Biosciences
Irvine, California, United Statesremybiosciences.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Commercial
01
Overview
Remy Biosciences has developed proprietary transdermal and sublingual delivery systems that provide 5-40 times more active ingredient delivery compared to competitors. Their technology bypasses first-pass metabolism for more effective drug delivery.
- Therapeutic areas
- ImmunologyOtherPsychiatryNeurologyWomen's Health
- Modalities
- Transdermal patchesSublingual tablets
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Remy Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Remy Biosciences.